2016【北京大学医学翻译社】笔试题目.docxVIP

北京大学医学翻译社2016年笔试题目姓名性别联系电话学院年级邮箱（本试题共分两部分，试题难度和长度与翻译社的日常翻译项目相当。第一部分为北医三院医讯简报翻译，中译英（包括题目）；第二部分为罕见病项目翻译，英译中。请您将翻译的译文写在原文的后面，并标注翻译所用时间。医学翻译社的同学会将您的翻译进行仔细批改并反馈）【第一部分】请将以下内容翻译成英文，谢绝抄袭。医院官方微信荣获“全国医院微信综合排名十强” 在11月27日至28日由医学界主办的首届“互联网+”下的医院宣传新变局暨第一届中国医院宣传年会上，我院官方微信公众平台荣获“2015年度全国医院微信综合排名十强”和“2015全国医院官方微信服务号二十强”。《为了一位羊水栓塞大出血产妇》一文获全国医院优秀原创文章奖，我院党院办副主任仰东萍获2015年度中国医院微信奉献奖。仰东萍以“当医院宣传遇到自媒体”为题，与参会同仁分享了工作实践与感受。译文：用时：约分钟【第二部分】Please translate the following essay into Chinese, any kind of plagiarism should be abandoned.The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.VWD is the most common inherited bleeding disorder, affecting approximately 1 percent of the U.S. population. Men and women are equally affected by VWD, which is caused by a deficiency or defect in von Willebrand factor, a protein that is critical for normal blood clotting. Patients with VWD can develop severe bleeding from the nose, gums, and intestines, as well as into muscles and joints. Women with VWD may have heavy menstrual periods lasting longer than average and may experience excessive bleeding after childbirth.The safety and efficacy of Vonvendi were evaluated in two clinical trials of 69 adult participants with VWD. These trials demonstrated that Vonvendi was safe and effective for the on-demand treatment and control of bleeding episodes from a variety of different sites in the body. No safety concerns were identified in the trials. The most common adverse reaction observed was generalized pruritus (itching).译文：用时：约分钟请您将翻译后的文档保存，重命名为“姓名-学院-年级”并于下周三中午12:00前发至pkumtacouncil@163.com，谢谢！北京大学医学翻译社